ROLE OF CALMODULIN IN PLATELET-AGGREGATION - STRUCTURE-ACTIVITY RELATIONSHIP OF CALMODULIN ANTAGONISTS

被引：65
|
作者：
NISHIKAWA, M [1 ]
HIDAKA, H [1 ]
机构：
[1] MIE UNIV, SCH MED, DEPT PHARMACOL, TSU, MIE 514, JAPAN
来源：
JOURNAL OF CLINICAL INVESTIGATION | 1982年 / 69卷 / 06期
关键词：
D O I：
10.1172/JCI110574
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1348 / 1355
页数：8
相关论文
共 50 条
  • [31] RELATIONSHIP BETWEEN STRUCTURE AND ACTIVITY OF ASPIRIN-RELATED COMPOUNDS ON THE INHIBITION OF INVITRO PLATELET-AGGREGATION
    DUPIN, JP
    GRAVIER, D
    CASADEBAIG, F
    BOISSEAU, MR
    BERNARD, H
    FARMACO-EDIZIONE SCIENTIFICA, 1986, 41 (03): : 205 - 214
  • [32] STRUCTURE-ACTIVITY-RELATIONSHIPS OF CANATOXIN EFFECTS ON PLATELET-AGGREGATION
    CARLINI, CR
    RIBEIRO, JMC
    GUIMARAES, JA
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 1982, 54 (04): : 762 - 763
  • [33] RELATIONSHIP OF CALMODULIN AND DOPAMINERGIC ACTIVITY IN THE STRIATUM
    GNEGY, ME
    FEDERATION PROCEEDINGS, 1982, 41 (07) : 2273 - 2277
  • [34] EFFECTS OF CA++-ANTAGONISTS ON PLATELET-AGGREGATION AND SECRETION
    MARGOLIS, B
    LUCAS, C
    HENRY, PD
    CIRCULATION, 1980, 62 (04) : 191 - 191
  • [35] EFFECT OF ANALOGS AND ANTAGONISTS OF PLATELET ACTIVATING FACTOR (PAF) ON PLATELET-AGGREGATION
    LAKIN, KM
    KULIKOV, VI
    MANEVICH, EM
    MULYAR, AG
    SHVETS, VI
    FARMAKOLOGIYA I TOKSIKOLOGIYA, 1988, 51 (04): : 113 - 123
  • [36] RELATIONSHIP BETWEEN PLATELET MONOAMINE-OXIDASE ACTIVITY AND EPINEPHRINE INDUCED PLATELET-AGGREGATION
    ROSSI, EC
    LOUIS, G
    BIEBER, M
    ZELLER, EA
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 453 - 453
  • [37] Chemistry of ginkgolides: structure-activity relationship as PAF antagonists
    Hu, LH
    Chen, ZL
    Cheng, XF
    Xie, YY
    PURE AND APPLIED CHEMISTRY, 1999, 71 (06) : 1153 - 1156
  • [38] Chemistry, design, and structure-activity relationship of cocaine antagonists
    Singh, S
    CHEMICAL REVIEWS, 2000, 100 (03) : 925 - 1024
  • [39] PHARMACOLOGICAL STUDIES ON STRUCTURE-ACTIVITY RELATIONSHIP OF MORPHINE ANTAGONISTS
    ANAND, DR
    ARZNEIMITTEL-FORSCHUNG, 1965, 15 (05): : 564 - &
  • [40] Quantitative structure-activity relationship studies on cholecystokinin antagonists
    Gupta, SP
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (02) : 111 - 124
12345